Home Industries Market Insights About Us Publisher Contact us

North America Organ-on-Chip Market 2020-2030 by Offering (Chips, Service), Organ Type (Liver, Heart, Lung, Kidney, Brain, Skin), Material (Polymers, Glass, Silicon), Application, End User, and Country: Trend Forecast and Growth Opportunity

Published Date : 30-Jul-2021

Report Id : HNY198728

Pages : 99

Region: North America

North America organ-on-chip market is expected to grow by 33.7% annually in the forecast period and reach $178.6 million by 2030 owing to the rising use of organ-on-a-chip (OOC) in early detection of drug toxicity, increasing demand for personalized medicine, the emergence of OOC as an alternative to animal testing, the significant increase in research funding and venture capital investments.
Highlighted with 23 tables and 47 figures, this 99-page report “North America Organ-on-Chip Market 2020-2030 by Offering (Chips, Service), Organ Type (Liver, Heart, Lung, Kidney, Brain, Skin), Material (Polymers, Glass, Silicon), Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America organ-on-chip market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America organ-on-chip market in every aspect of the classification from perspectives of Offering, Organ Type, Material, Application, End User, and Country.
Based on Offering, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Chips
• Service
Based on Organ Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Liver-on-a-Chip
• Heart-on-a-Chip
• Lung-on-a-Chip
• Kidney-on-a-Chip
• Brain-on-a-Chip
• Skin-on-a-Chip
• Vessels-on-a-Chip
• Other Organ Types
Based on Material, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Polymers
• Glass
• Silicon
Based on Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Drug Discovery
• Toxicology Research
• Other Applications
Based on End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Cosmetics Industry
• Other End Users
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Organ Type, Application, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
AxoSim Inc.
BiomimX SRL
Cherry Biotech
CN Bio Innovations, Ltd.
Emulate Inc.
Hurel Corporation
InSphero AG
Kirkstall, Ltd.
MIMETAS BV
Nortis Inc.
Organovo, Inc.
SynVivo, Inc.
Tara Biosystems Inc.
TissUse GmbH
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 22
2.2 Major Growth Drivers 24
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porter’s Fiver Forces Analysis 36
3 Segmentation of North America Market by Offering 40
3.1 Market Overview by Offering 40
3.2 Chips 42
3.3 Service 43
4 Segmentation of North America Market by Organ Type 44
4.1 Market Overview by Organ Type 44
4.2 Liver-on-a-Chip 46
4.3 Heart-on-a-Chip 47
4.4 Lung-on-a-Chip 48
4.5 Kidney-on-a-Chip 49
4.6 Brain-on-a-Chip 50
4.7 Skin-on-a-Chip 51
4.8 Vessels-on-a-Chip 52
4.9 Other Organ Types 53
5 Segmentation of North America Market by Material 54
5.1 Market Overview by Material 54
5.2 Polymers 56
5.3 Glass 57
5.4 Silicon 58
6 Segmentation of North America Market by Application 59
6.1 Market Overview by Application 59
6.2 Drug Discovery 61
6.3 Toxicology Research 62
6.4 Other Applications 63
7 Segmentation of North America Market by End User 64
7.1 Market Overview by End User 64
7.2 Pharmaceutical and Biotechnology Companies 66
7.3 Academic and Research Institutes 67
7.4 Cosmetics Industry 68
7.5 Other End Users 69
8 North America Market 2019-2030 by Country 70
8.1 Overview of North America Market 70
8.2 U.S. 73
8.3 Canada 76
8.4 Mexico 78
9 Competitive Landscape 80
9.1 Overview of Key Vendors 80
9.2 New Product Launch, Partnership, Investment, and M&A 83
9.3 Company Profiles 84
AxoSim Inc. 84
BiomimX SRL 86
Cherry Biotech 87
CN Bio Innovations, Ltd. 88
Emulate Inc. 89
Hurel Corporation 90
InSphero AG 91
Kirkstall, Ltd. 92
MIMETAS BV 93
Nortis Inc. 94
Organovo, Inc. 95
SynVivo, Inc. 96
Tara Biosystems Inc. 97
TissUse GmbH 98
RELATED REPORTS 99
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16
Figure 4. North America Organ-on-Chip Market, 2019-2030, $ mn 19
Figure 5. Impact of COVID-19 on Business 22
Figure 6. Primary Drivers and Impact Factors of North America Organ-on-Chip Market 24
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 27
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 27
Figure 9. Primary Restraints and Impact Factors of North America Organ-on-Chip Market 29
Figure 10. Investment Opportunity Analysis 33
Figure 11. Porter’s Fiver Forces Analysis of North America Organ-on-Chip Market 36
Figure 12. Breakdown of North America Organ-on-Chip Market by Offering, 2019-2030, % of Revenue 41
Figure 13. North America Addressable Market Cap in 2021-2030 by Offering, Value ($ mn) and Share (%) 41
Figure 14. North America Organ-on-Chip Market: Chips, 2019-2030, $ mn 42
Figure 15. North America Organ-on-Chip Market: Service, 2019-2030, $ mn 43
Figure 16. Breakdown of North America Organ-on-Chip Market by Organ Type, 2019-2030, % of Sales Revenue 45
Figure 17. North America Addressable Market Cap in 2021-2030 by Organ Type, Value ($ mn) and Share (%) 45
Figure 18. North America Organ-on-Chip Market: Liver-on-a-Chip, 2019-2030, $ mn 46
Figure 19. North America Organ-on-Chip Market: Heart-on-a-Chip, 2019-2030, $ mn 47
Figure 20. North America Organ-on-Chip Market: Lung-on-a-Chip, 2019-2030, $ mn 48
Figure 21. North America Organ-on-Chip Market: Kidney-on-a-Chip, 2019-2030, $ mn 49
Figure 22. North America Organ-on-Chip Market: Brain-on-a-Chip, 2019-2030, $ mn 50
Figure 23. North America Organ-on-Chip Market: Skin-on-a-Chip, 2019-2030, $ mn 51
Figure 24. North America Organ-on-Chip Market: Vessels-on-a-Chip, 2019-2030, $ mn 52
Figure 25. North America Organ-on-Chip Market: Other Organ Types, 2019-2030, $ mn 53
Figure 26. Breakdown of North America Organ-on-Chip Market by Material, 2019-2030, % of Sales Revenue 55
Figure 27. North America Addressable Market Cap in 2021-2030 by Material, Value ($ mn) and Share (%) 55
Figure 28. North America Organ-on-Chip Market: Polymers, 2019-2030, $ mn 56
Figure 29. North America Organ-on-Chip Market: Glass, 2019-2030, $ mn 57
Figure 30. North America Organ-on-Chip Market: Silicon, 2019-2030, $ mn 58
Figure 31. Breakdown of North America Organ-on-Chip Market by Application, 2019-2030, % of Revenue 60
Figure 32. North America Addressable Market Cap in 2021-2030 by Application, Value ($ mn) and Share (%) 60
Figure 33. North America Organ-on-Chip Market: Drug Discovery, 2019-2030, $ mn 61
Figure 34. North America Organ-on-Chip Market: Toxicology Research, 2019-2030, $ mn 62
Figure 35. North America Organ-on-Chip Market: Other Applications, 2019-2030, $ mn 63
Figure 36. Breakdown of North America Organ-on-Chip Market by End User, 2019-2030, % of Revenue 65
Figure 37. North America Addressable Market Cap in 2021-2030 by End User, Value ($ mn) and Share (%) 65
Figure 38. North America Organ-on-Chip Market: Pharmaceutical and Biotechnology Companies, 2019-2030, $ mn 66
Figure 39. North America Organ-on-Chip Market: Academic and Research Institutes, 2019-2030, $ mn 67
Figure 40. North America Organ-on-Chip Market: Cosmetics Industry, 2019-2030, $ mn 68
Figure 41. North America Organ-on-Chip Market: Other End Users, 2019-2030, $ mn 69
Figure 42. Breakdown of North America Organ-on-Chip Market by Country, 2019 and 2030F, % of Revenue 71
Figure 43. Contribution to North America 2021-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 72
Figure 44. U.S. Organ-on-Chip Market, 2019-2030, $ mn 74
Figure 45. Canada Organ-on-Chip Market, 2019-2030, $ mn 76
Figure 46. Organ-on-Chip Market in Mexico, 2015-2030F, $ mn 78
Figure 47. Growth Stage of North America Organ-on-Chip Industry over the Forecast Period 80

Request For Discount

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any), so we can get back to you with a solution

Buy Now

Single User

US$ 2800

Multi User

US$ 3900

Corporate User

US$ 4900

Related Reports

North America Organ-on-Chip Market 2020-2030 by Of...

RD Code : HNY198728